Mizuta T, Fujiwara M, Hatta T, Abe T, Miyano-Kurosaki N, Shigeta S, Yokota T, Takaku H
Rational Drug Design Laboratories, Makutsawa-Machi, Fukushima, Japan.
Nat Biotechnol. 1999 Jun;17(6):583-7. doi: 10.1038/9893.
We have investigated the ability of antisense phosphorothioate oligonucleotides to enhance the survival of mice infected with influenza A virus. The oligonucleotides were complementary to sequences surrounding the translation initiation codons of the viral PB2 or PA genes (PB2-as or PA-as, respectively) of the influenza A virus RNA polymerases. Intravenous administration of PB2-as in a complex with a cationic liposome, Tfx-10, significantly prolonged the mean survival time in days and increased overall survival rates of mice infected with the influenza A virus. Liposomally encapsulated PB2-as inhibited viral growth in lung tissues and reduced pulmonary consolidations. Liposomally encapsulated PB2-as could be an effective therapeutic agent against influenza A virus.
我们研究了反义硫代磷酸酯寡核苷酸增强感染甲型流感病毒小鼠存活率的能力。这些寡核苷酸与甲型流感病毒RNA聚合酶的病毒PB2或PA基因(分别为PB2-as或PA-as)翻译起始密码子周围的序列互补。将PB2-as与阳离子脂质体Tfx-10复合后静脉注射,显著延长了感染甲型流感病毒小鼠的平均存活天数,并提高了总体存活率。脂质体包裹的PB2-as抑制了肺组织中的病毒生长,并减少了肺部实变。脂质体包裹的PB2-as可能是一种有效的抗甲型流感病毒治疗剂。